New Key Statistics Module, Z-Score and F-Score
WBO:MRNA Key Ratios
| Market Cap € M | 50,438.40 |
| Enterprise Value € M | 43,711.53 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.57 |
| Price/Sales | 11.46 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 4,699.00 |
| EPS (TTM) € | -14.59 |
| Beneish M-Score | -3.78 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -183.90 |
| EV-to-EBIT | -9.90 |
| EV-to-EBITDA | -11.27 |
| PEG | -- |
| Shares Outstanding M | 383.24 |
| Net Margin (%) | -117.41 |
| Operating Margin % | -101.10 |
| Pre-tax Margin (%) | -94.47 |
| Quick Ratio | 3.91 |
| Current Ratio | 4.03 |
| ROA % (ttm) | -29.66 |
| ROE % (ttm) | -39.30 |
| ROIC % (ttm) | -58.09 |
| Dividend Yield % | -- |
| Altman Z-Score | 9.83 |
WBO:MRNA Number of Guru Trades
WBO:MRNA Volume of Guru Trades
Gurus Latest Trades with WBO:MRNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WBO:MRNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers